Authors
Li-Ping Wang, Long-Feng Ke, Yun-Li Xie, Huan-Huan Zhu, Shu-Yi Lu, Wen-Wen Zhang, Yu Chen, Gang Chen, Yan-Ping Chen
Published in
Archives of pathology & laboratory medicine. Oct 15, 2026. Epub Oct 15, 2026.
Abstract
Several studies have reported the prognostic and therapeutic response value of tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) in patients with melanoma. However, the prognostic correlation of these markers assessed by immunohistochemistry staining remains contradictory.
To investigate the impact of TILs and TLSs on progression-free survival (PFS) and overall survival (OS) across melanoma subtypes.
Immunohistochemical staining for CD3, CD4, CD8, forkhead box protein 3 (FOXP3), CD20, and PD-L1 (programmed cell death-ligand 1) was combined with automated image analysis for density quantification. Cox regression and Kaplan-Meier analysis evaluated the effects of PD-L1 expression and TIL and TLS distribution on PFS and OS.
Clinicopathologic subtypes differed in multiple factors including TILs and immune cell counts. Kaplan-Meier analysis showed high intratumoral CD3+ (iCD3+), intratumoral CD8+ (iCD8+), and intratumoral CD20+ (iCD20+) cell counts and low peritumoral FOXP3+ (pFOXP3+) cell counts correlated with shorter OS; and high iCD8+ and iCD20+ cell counts and low intratumoral FOXP3+ (iFOXP3+), peritumoral CD4+ (pCD4+), and pFOXP3+ cell counts correlated with worse PFS. Multivariate Cox regression identified lymph node metastasis, iCD8+ and pFOXP3+ cells as independent OS prognostic factors; and mitotic count, lymph node metastasis, iCD8+ and iFOXP3+ cells as independent PFS prognostic factors.
In this exploratory, hypothesis-generating study of Chinese patients with primary melanoma, TIL subgroups showed significant prognostic value, while PD-L1 expression did not. Owing to the modest sample size and single-center design, these findings require validation in larger, multicenter cohorts before clinical translation.
PMID:
43042928
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0